New York, NY: September 22, 2010 – The M&A Advisor, a leading investment banking publication, selected Anthony G. Viscogliosi, Founder, Chairman & CEO of Small Bone Innovations, Inc. (SBi), as a recipient of the International Equity Financing of the Year award. Mr. Viscogliosi will receive the award at a luncheon in New York on September 27th.

Mr. Viscogliosi will receive the award for the private equity, Series D funding of $113 million of SBi, a leading, privately held orthopedics company focused primarily on arthroplasty and trauma reconstruction technology and treatments for the small bones & joints. The funding which commenced in late 2008 was completed in November 2009 during a period of virtual paralysis in the capital markets. Investors included: Goldman, Sachs & Co., Khazanah Nasional Berhad (the Sovereign Wealth Fund of the Government of Malaysia), Malaysian Technology Development Corporation (MTDC), an integrated Malaysia-based venture capital company, The Family Office of Bahrain, Trevi Health Ventures, NGN Capital, TGap Ventures and Axiom Venture Partners, among others.

Mr. Viscogliosi said: "In view of the extremely difficult conditions in the global capital markets, the scope and quality of this investment round was an affirmation of SBi’s business model and a recognition of the small bone & joint market as the fastest growing sector in orthopedics."

The selection criteria for The M&A Advisor award included quantitative factors such as transaction value, impact on shareholder/company value and market share. Qualitative considerations included impact of transaction on the market/industry, ingenuity in structuring and/or negotiations, diligence and perseverance in consummating the deal and other unique attributes.

Mr. Viscogliosi, a Principal of New York merchant bank Viscogliosi Bros., LLC, has 26 years of experience as an accomplished founder, entrepreneur, CEO, board member, leading Wall Street analyst, banker, global financier, author, visionary and lecturer. He was the first Wall Street orthopedic industry analyst and has authored nearly 7,000 pages of investment research on orthopedics. He has executed more than 190 orthopedic deals of every type as principal or agent, buyer or seller. Mr. Viscogliosi has founded more than 20 companies and serves or served as Chairman, CEO, President or Managing Member of 12 businesses. Furthermore, he served on the board of more than 15 companies. Mr. Viscogliosi has been responsible for generating nearly $1 billion in investment returns and has been involved in raising nearly $2 billion in capital for businesses participating in the orthopedic industry.

Mr. Viscogliosi attended the Henry Ford Community College in 1980, Lawrence Institute of Technology, School of Architecture in 1980 and 1981, and graduated from the University of Michigan-Dearborn with a B.A. in Economics in 1984. He graduated from the U.S. NAVY Supply Corps School, Athens, Georgia in 1992, and was a recipient of the New York College of Podiatric Medicine Honorary Doctorate of Humane Letters in 2007.

Mr. Viscogliosi was direct-commissioned as an officer in the U.S. Navy Reserve in 1990 during Operation Desert Shield, and is currently a Lieutenant Commander United States Navy Reserve. He served on-board the aircraft carrier USS Theodore Roosevelt, CVN-71, during the beginning of the NATO/Bosnia war in 1995, and has served in the Middle East on annual training assignments conducting activities in Jordan and Bahrain. He has served on several annual training assignments in Korea including the beginning of the Iraq war in 2003. He also served as Assistant Officer-In-Charge and Supply Corp Officer for the U.S. Navy Ceremonial Guard in 2000/2001, which serves the President of the United States of America, Vice President, Secretary of Defense, Secretary of the Navy and the Joint Chiefs of Staff during Active Duty for Special Work. Mr. Viscogliosi earned the Designation and Warfare Qualification of Naval Aviation Supply Corp Officer in 1998, one of only a few hundred in the U.S. Armed Forces. He was awarded with the US Navy Commendation Medal for his actions on 9/11 in New York City, at the World Trade Center.

SBi has been attracting considerable attention in recent months in both the financial and the orthopedics sector. Out of nearly 5,200 companies considered, SBi was the only orthopedic company on the list of the top 50 U.S. VC-backed companies in the Wall Street Journal article "Sizing Up Promising Young Firms" on March 9, 2010. Additionally, SBi was the 7th highest ranked healthcare company and was 24th amongst all 50 companies highlighted.

About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Brothers, LLC, (VB), a New York-based merchant banking firm that specializes in the musculoskeletal/orthopedics sector. VB created SBi as the first company to focus purely on small bones & joints. By integrating established companies and professionals in the field, SBi offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints. Today, SBi has facilities in New York, NY, Morrisville, PA, Bourg-en-Bresse, France, Donaueschingen, Germany, and Kuala Lumpur, Malaysia and has sold its products in 46 countries.

For more information on SBi, please visit:

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated exclusively to the musculoskeletal/orthopedics sector of the health care industry.

VB's mission is to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. Marc, Anthony and John Viscogliosi have executed multiple financial, strategic and management transactions for companies in the musculoskeletal/orthopedic sector.

Forward-looking statements
This news release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting SBi's business including increased competition; the ability of SBi to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.

> Back to Press Releases


Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.